CHPs empower researchers to precisely detect, monitor, and study fibrosis dynamics, transforming our understanding of subretinal fibrosis in nAMD.
CHPs enable precise detection of remodeling collagen, helping researchers identify fibrotic regions within SHRM with unmatched accuracy.
CHPs facilitate real-time tracking of fibrosis progression, regression, or stabilization, offering valuable insights into disease evolution.
CHPs provide a reliable metric to measure therapeutic efficacy, enabling precise evaluation of anti-fibrotic treatments in nAMD.
CHPs support the identification of fibrosis-related biomarkers, paving the way for targeted therapies and personalized treatment strategies.
Thanks for subscribing!
This email has been registered!